Skip to content
Bomb Report – Lifestyle
Author:
Royal Biologics
Royal Biologics Announces FDA Clearance for Fibrinet® PRF Wound Matrix for the Management of Cutaneous Wounds
April 7, 2026
Royal Biologics Announces Strategic Partnership with Jellagen (UK) to Bring Jellyfish-Derived Collagen Type Zero to the U.S. Regenerative Medicine Market
March 5, 2026